Stocks›Healthcare›AXGN

AXGN

Axogen, Inc.

NasdaqResearch view

Healthcare · Electromedical & Electrotherapeutic Apparatus · Mid-cap · SEC EDGAR FY 2025-12-31

Price history

Chart: TradingView’s own feed · page prices: 1D EOD

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$2.4B

Enterprise Value$2.5B

Income$-15.7M

Sales$225.2M

Book/sh$2.40

Cash/sh$0.74

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio3.31

Current Ratio5.11

Debt/Eq0.39

EPS (ttm)$-0.34

EPS this Y-47.8%

EPS past 3/5Y—

Sales past 3/5Y17.6%

EPS Y/Y TTM-47.8%

Sales Y/Y TTM20.2%

Shs Outstand53.76M

ROA-7.1%

ROE-12.2%

ROIC-5.6%

Gross Margin74.3%

Oper. Margin-3.5%

Profit Margin-7.0%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

$127.4M

2021

$138.6M

2022

$159.0M

2023

$187.3M

2024

$225.2M

2025

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$127.4M	$138.6M	$159.0M	$187.3M	$225.2M
Gross Profit	$104.4M	$108.8M	$121.9M	$142.0M	$167.4M
Operating Income	$-25.4M	$-29.7M	$-21.5M	$-3.3M	$-7.8M
Net Income	$-27.0M	$-28.9M	$-21.7M	$-10.0M	$-15.7M
Diluted EPS	$-0.65	$-0.69	$-0.51	$-0.23	$-0.34
Operating Cash Flow	$-13.4M	$-16.1M	$-5.7M	$4.5M	$812,000
Free Cash Flow	$-41.2M	$-36.1M	$-19.6M	$1.4M	$-2.9M